此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

The Effect of Using Plaque-disclosing Tablets on the Effectiveness of Toothbrushing and Gingival Health in Children

2026年11月3日 更新者:Ezgi Sila Taskaldiran

Effect of Single-Use Plaque-Disclosing Tablet Reinforcement on Plaque Control and Gingival Health in Children: A Randomized Controlled Clinical Trial

This randomized controlled clinical trial evaluated whether a single at-home use of a plaque-disclosing tablet, as visual reinforcement following oral hygiene education, provides additional short-term benefits in plaque control and gingival health in children aged 10-14 years.

A total of 53 participants were randomized to a test group or a control group. All participants received plaque disclosure and standardized oral hygiene instruction including the modified Bass toothbrushing technique. Participants in the test group were additionally provided with one plaque-disclosing tablet to use on the fourth day after the initial visit, whereas the control group received no additional intervention. Plaque and gingival indices were recorded at baseline and again at the end of the first week.

研究概览

研究类型

介入性

注册 (实际的)

53

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

10年 至 14年 (孩子)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Children aged 10-14 years
  • Systemically and mentally healthy
  • No antibiotic use within the previous 3 months
  • No use of oral mouthrinse within the previous 4 weeks
  • No previous periodontal treatment
  • No known allergy or hypersensitivity to any component of the plaque-disclosing agent
  • Written informed consent provided by a parent or legal guardian
  • Voluntary assent provided by the child

Exclusion Criteria:

  • Presence of any systemic or mental condition that could interfere with participation
  • Antibiotic use within the previous 3 months
  • Use of oral mouthrinse within the previous 4 weeks
  • History of periodontal treatment
  • Known allergy or hypersensitivity to any component of the plaque-disclosing agent
  • Refusal of parental/legal guardian consent or child assent

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Test

Standard oral hygiene education + baseline plaque disclosure + single plaque-disclosing tablet reinforcement on day 4.

Participants received plaque disclosure followed by individualized visual feedback and standardized oral hygiene instruction using the modified Bass toothbrushing technique.

Participants in the experimental arm were provided with one plaque-disclosing tablet and instructed to use it at home on the fourth day after the initial visit as a single visual reinforcement of the oral hygiene education.

有源比较器:Control

Standard oral hygiene education + baseline plaque disclosure only.

Participants received plaque disclosure followed by individualized visual feedback and standardized oral hygiene instruction using the modified Bass toothbrushing technique.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in Quigley-Hein Plaque Index
大体时间:From enrollment to the end of treatment at 1 week

Plaque accumulation was assessed using the Quigley-Hein Plaque Index at the full-mouth level and separately for the incisor, canine, premolar, and molar regions. Scores were recorded at baseline and at the end of the first week. Lower scores indicate lower plaque accumulation.

From enrollment to the end of treatment at 1 week

次要结果测量

结果测量
措施说明
大体时间
Change in Gingival Index
大体时间:From enrollment to the end of treatment at 1 week

Gingival health was assessed using the Gingival Index at the full-mouth level. Scores were recorded at baseline and at the end of the first week. Lower scores indicate better gingival health.

From enrollment to the end of treatment at 1 week

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年4月29日

初级完成 (实际的)

2026年7月17日

研究完成 (实际的)

2026年8月21日

研究注册日期

首次提交

2026年11月3日

首先提交符合 QC 标准的

2026年11月3日

首次发布 (实际的)

2026年11月9日

研究记录更新

最后更新发布 (实际的)

2026年11月9日

上次提交的符合 QC 标准的更新

2026年11月3日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅